Laboratory and virology
WHO has an extensive global influenza laboratory network, isolating and typing influenza viruses from around the world. The data, and viruses from this network are used for the monitoring of influenza and the development of seasonal and pandemic vaccines.
-
Standardization of terminology for the variant A(H3N2) virus recently infecting humans
23 December 2011 -
Updated unified nomenclature system for the highly pathogenic H5N1 avian influenza viruses
21 October 2011 -
Standardization of terminology of the pandemic
A(H1N1)2009 virus
18 October 2011 -
WHO criteria for accepting positive PCR test results of H5 infection in humans from national reference laboratories
30 May 2011 -
Manual for the laboratory diagnosis and virological surveillance of influenza
29 April 2011 -
Safe transport of pandemic influenza A(H1N1)2009 virus cultures, isolates and patient specimens as Biological Substance, Category B
28 March 2010 -
WHO Information for the molecular diagnosis of influenza virus in humans - update
23 November 2009 -
Recommendations and laboratory procedures for detection of avian influenza A(H5N1) virus in specimens from suspected human cases
30 August 2007 -
WHO guidance on development of influenza vaccine reference viruses by reverse genetics
17 June 2005 -
WHO guidelines for the storage and transport of human and animal specimens for laboratory diagnosis of suspected avian influenza A infection
12 January 2005 -
WHO laboratory biosafety guidelines for handling specimens suspected of containing avian influenza A virus
12 January 2005